title: The pretransition of dipalmitoyllecithin bilayers as probed by the fluorescent pyrrolopyrimidine, U-104067.
abstract: The amphiphilic pyrrolopyrimidine, U-104067, is a fluorophore ideally suited to report on the relative hydrophobicities of different microenvironments. It forms stable monomolecular layers at the air/water interface with a limiting molecular area of 51.9 +/- 0.3 A2/molecule and a collapse pressure of about 18 dyn/cm. Differential scanning calorimetry of its mixed liposomes with dipalmitoyllecithin shows full solubility of the compound in the liquid disordered phase and insolubility in the solid ordered phase. In aqueous solutions, the compound binds to phospholipid bilayers with a stoichiometry of 13.2 +/- 1.2 moles of lipid per mole of U-104067, with Kd = 0.33 +/- 0.05 microM toward egg lecithin/phosphatidylserine bilayers and Kd = 1.5 +/- 0.3 microM toward pure egg lecithin bilayers. In liquid crystalline phospholipid bilayers the compound behaves as two independently emitting species, one accessible to acrylamide and the other one not. Doxyl fatty acid methyl esters quench both species and show that the average position of the fluorophore is at a depth corresponding to that of the 7th carbon of a fatty acyl chain. Dissolved in the liquid disordered (L alpha) phase of dipalmitoyllecithin at 45 degrees C, U-104067 shows a single ionizable group, pKa = 3.19 +/- 0.03 while in the solid ordered (L beta) phase it displays two ionizable groups, pKa1 = 4.99 +/- 0.10 and pKa2 = 6.96 +/- 0.13. The most unusual property of this molecule is that it is miscible with the tilted (L beta) and liquid (L alpha) phases of dipalmitoyllecithin but totally immiscible with the rippled (P beta) phase. Because of this, U-104067 is a sensitive reporter for the tilted/rippled phase transition as monitored by its fluorescence anisotropy and its quantum yield changes.
authors.affiliation: Pharmacia & Upjohn Inc., Kalamazoo, MI 49001, USA.
authors.forename: D E
authors.initials: DE
authors.lastname: Epps
authors.forename: C L
authors.initials: CL
authors.lastname: Wilson
authors.forename: A F
authors.initials: AF
authors.lastname: Vosters
authors.forename: F J
authors.initials: FJ
authors.lastname: Kézdy
mesh_terms: D015060:1,2-Dipalmitoylphosphatidylcholine / Q000737:chemistry* / Q000378:metabolism; D020106:Acrylamide; D000178:Acrylamides / Q000494:pharmacology; D002152:Calorimetry, Differential Scanning; D005227:Fatty Acids / Q000378:metabolism; D005454:Fluorescence Polarization; D005456:Fluorescent Dyes / Q000737:chemistry* / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D008051:Lipid Bilayers / Q000737:chemistry* / Q000378:metabolism; D008081:Liposomes / Q000378:metabolism; D015394:Molecular Structure; D010713:Phosphatidylcholines / Q000378:metabolism; D011743:Pyrimidines / Q000737:chemistry* / Q000378:metabolism; D011759:Pyrrolidines / Q000737:chemistry* / Q000378:metabolism; D012995:Solubility; D012997:Solvents; D013050:Spectrometry, Fluorescence; D013696:Temperature
chemical_list: D000178:Acrylamides; D005227:Fatty Acids; D005456:Fluorescent Dyes; D008051:Lipid Bilayers; D008081:Liposomes; D010713:Phosphatidylcholines; D011743:Pyrimidines; D011759:Pyrrolidines; D012997:Solvents; D020106:Acrylamide; D015060:1,2-Dipalmitoylphosphatidylcholine; C096239:U 104067